Microbiología y CCS

Contamination control strategy has become the document inspectors judge first. See the 5 questions MHRA and FDA kept asking over the last 18 months.

A single antibiotic course can disrupt gut bacteria for months, affecting the gut-skin axis. Discover the hidden microbiome trajectory.

Hospital-acquired infection risk is shaped by microbial balance, not just single pathogens. Explore the 99% AMR-reduction trial data.

Mycoplasma is invisible to routine checks. Modern risk management combines prevention, rapid detection, and compliant response.

EU GMP Annex 1 made zero CFU the new Grade A standard. Here's how it's reshaping contamination control, EM programmes, and pharma microbiology.

How a compliant environmental monitoring programme became a blindfold, and what every sterile facility should ask before the next contamination event.

A 14-day sterility test can outlast a product's shelf life. Here's how RMMs cut detection time and stay FDA, EMA compliant.

Turbulence is the hidden contamination risk in sterile manufacturing, First Air, smoke studies, isolators and Annex 1 explained.

Biofilms resist antibiotics, evade immune defenses, and persist on medical devices. Here's why they remain one of pharma's toughest challenges.